Employees Provident Fund Board

Position in AMGN — Amgen Inc

CIK 1600177 Shah Alam, N8

Position in AMGN

as of Mar 31, 2026 · filed May 12, 2026 Compact

Position Value

$18,961,900

-$6,731,935 QoQ

Shares Held

53,892

-31.3% QoQ

Ownership

0.010%

of shares outstanding

% of Portfolio

0.15%

of 13F equity value

Holder Rank

—

not a current holder

Holding Since

Mar 2020

14 quarters on record

Voting authority Sole 100.ToString("F0")% Shared 0.ToString("F0")% None 0.ToString("F0")%

Healthcare · as of Mar 31, 2026

Employees Provident Fund Board holds $1,134,862,339 across 8 Drug Manufacturers - General names. AMGN ranks #8 (1.7% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	LLY	ELI LILLY & Co	524,361	$482,291,516
2	MRK	Merck & Co., Inc.	1,895,165	$227,969,397
3	BMY	Bristol Myers Squibb Co	2,509,000	$152,170,850
4	BIIB	Biogen Inc.	704,196	$129,100,252
5	GILD	Gilead Sciences, Inc.	346,000	$48,222,020
6	JNJ	Johnson & Johnson	182,381	$44,581,211
7	ABBV	AbbVie Inc.	145,134	$31,565,193
8	AMGN	Amgen Inc This page	53,892	$18,961,900

14 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-03-31	$18,961,900	53,892	-31.3%	Shares	Sole	2026-05-12
2025-12-31	$25,693,835	78,500	-3.1%	Shares	Sole	2026-03-03
2025-09-30	$22,858,200	81,000	+2.7%	Shares	Sole	2026-03-17
2025-06-30	$22,031,623	78,907	+57.2%	Shares	Sole	2026-03-17
2025-03-31	$15,639,810	50,200	-11.9%	Shares	Sole	2026-03-17
2024-12-31	$14,856,480	57,000	+37.0%	Shares	Sole	2026-03-17
2024-09-30	$13,403,936	41,600	-0.5%	Shares	Sole	2026-03-17
2024-06-30	$13,060,410	41,800	-12.9%	Shares	Sole	2026-03-18
2024-03-31	$13,647,360	48,000	-4.0%	Shares	Sole	2026-03-18
2023-12-31	$14,401,000	50,000	+8.7%	Shares	Sole	2026-03-18
2023-09-30	$12,362,960	46,000	-12.4%	Shares	Sole	2026-03-18
2023-06-30	$11,656,050	52,500	+58.6%	Shares	Sole	2026-03-31
2023-03-31	$8,001,925	33,100	-17.0%	Shares	Sole	2026-03-18
2020-03-31	$8,088,521	39,898	—	Shares	Sole	2026-03-20
No filing history on record for this holder in this stock.